Profile of NFÊBp(65/NF¦ÊBp50) among prostate specific antigen sera levels in prostatic pathologies
详细信息    查看全文
文摘

Aim

The aim of this work was to characterise the immunoexpression of NFÊB (p50/p65) in human prostatic pathologies and to study its profiles of activation among sera prostate specific antigen antigen (PSA) according the three groups: 0-4 ng/mL, 4-20 ng/mL and > 20 ng/mL.

Patients and methods

Twenty-four men with benign prostate hyperplasia (BPH); 19 men with prostate cancer (PC) and five men with normal prostates (NP). Immunohistochemical and western blot analysis was performed. Serum levels of PSA were assayed by immulite autoanalyser.

Results

In BPH and PC samples, immunoexpressions were observed for NF-¦ÊBp65 and NF-¦ÊBp50; while in NP samples, only were detected NF-¦ÊBp50. PC samples showed immunoreactions to NF-¦ÊBp65 and NF-¦ÊBp50 more intense (respectively 24.18 ¡À 0.67 and 28.23 ¡À 2.01) than that observed in BPH samples (respectively18.46 ¡À 2.04 and 18.66 ¡À 1.59) with special localisation in the nucleus. Different profiles of NF-¦ÊBp65 immunoexpressions were observed and BPH patients with sera PSA levels between 0-4 ng/mL presented a significant weak percentage compared to BPH patients with sera PSA levels between 4-20 ng/mL and > 20 ng/mL. No immunoreactions to NF-¦ÊBp65 were observed in PC patients with sera PSA levels between 4-20 ng/mL.

Conclusion

The sensibility of both NF-¦ÊB and PSA to inflammation allowed confirming the relationship between these two molecules and its involvement in prostatic diseases progression (inflammatory and neoplasic).

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700